I have made a small addition to the Cellestis Growth Projection Spreadsheet.
We know that the Sales for 2010 equated to 1.81m tests. Because our Sales Growth percentage represents the growth in native currencies it is a proxy for volume growth also. Therefore, we can apply the same growth factor to the number of tests sold to have a look at the projected market penetration.
I have included these figures in the spreadsheet.
Hi Forrest,
ReplyDeleteThanks for the projections tables. I note there is an ever growing Cash component - I presume this is set aside for some M&A or licensing of out of house science or perhaps some more R&D. I think I would rather see this remain at about the $20m mark and then pass the the remainder onto us shareholders. If they need urgent cash more than $20m then let them go to the bank.
draughtsman